Allspring Global Investments
LEGN icon

Allspring Global Investments’s Legend Biotech LEGN Stock Holding History

Allspring Global Investments’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-485
Closed -$23.6K – 2118
2024
Q3 		$23.6K Buy
+485
New +$25.8K ﹤0.01% 1976

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Allspring Global Investments's LEGN Position: Q4 2024 in Review

Allspring Global Investments sold out of Legend Biotech (LEGN) in Q4 2024, closing a stake of 485 shares — an estimated $23.6K sold.

Allspring Global Investments first reported a position in LEGN in Q3 2024 and held it in 1 quarter. The position peaked at $23.6K in Q3 2024. 211 funds tracked by Wall St. Rank hold LEGN as of Q4 2024.

  • Allspring Global Investments reported no remaining Legend Biotech position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 485 Legend Biotech shares in Q4 2024, an estimated $23.6K.
  • Allspring Global Investments first reported a position in Legend Biotech in Q3 2024 and held it in 1 quarter.
  • Allspring Global Investments's Legend Biotech position peaked at $23.6K in Q3 2024.
  • 211 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.